How Cronos Group Is Growing Its Core Medical Marijuana Business

📆 2018-09-28 04:21:00
📰 Forbes

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 53%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

Cronos Group has seen its stock price rise by over 70% over the last six months. While the rally has largely been driven by legalization in Canada and deal-making activity in the industry, Cronos’ bread-and-butter medical marijuana business is likely to remain a crucial driver for the company.

Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

Skriv Kommentar

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Altria in talks to buy cannabis company Cronos GroupMarlboro cigarette maker Altria is in early talks to acquire Canadian cannabis producer Cronos, as it seeks to diversify its business beyond traditional smokers, a person familiar with the matter told CNBC. 😳🙄 Uwu uwu...cokiegig88 it doesn't take much to get these guys going...
Källa: CNBC - 🏆 12. / 72 Läs mer »

Marlboro maker Altria is talking with pot producer Cronos about investmentMarlboro cigarette maker Altria Group Inc. is discussing an investment in marijuana producer Cronos Group Inc., as legacy companies continue to look for ways into the marijuana industry.
Källa: MarketWatch - 🏆 3. / 97 Läs mer »

Altria to invest $1.8 billion in cannabis company Cronos GroupAltria Group said Friday it agreed to buy a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion. That was the complete value of the company, as of yesterdays close. IMO Altria will own the company outright in a few years, with no more capital outlay. Bad idea legalizing dope. Drug dealers are now legal.
Källa: CNBC - 🏆 12. / 72 Läs mer »